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 Ebola: Protecting Healthcare Workers 
Martha McCoy RN 
Introduction: 
Pathophysiological Processes: 
 Otterbein University, Westerville, Ohio  
Underlying Pathophysiology: 
Ebola is a hemorrhagic disease 
that has been seen throughout Liberia, 
but because of international travel it is 
spreading. Gilsdorf, Morgan and 
Leitmeyer (2012) researched air travel 
and reported that, “In 2010, 5.04 billion 
passengers arrived and departed from 
1318 airports worldwide… and travel to 
and from Africa almost doubled 
between 1995 and 2005.” (p.1471). In 
the last few months there have been 
cases of Ebola reported in Spain and the 
United States linked to travel.  
 These are recent developments 
because as of July, 2014 the Center for 
Disease Control and Prevention (CDC) 
reported “to date there are no cases 
reported in the United States.” (CDC, 
2014). Turner (2014) reports that “the 
incubation period can be as long as 21 
days.” (p.68) This gives exposed people 
a chance to travel to any place in the 
world and expose others to this 
potentially fatal virus. The public that 
flies in planes may have a risk, but the 
people that are at greater risk are 
healthcare workers that care for Ebola 
patients.  
When researching Ebola it was revealed that infected individuals have been 
known to fly to other countries while infected, but the risk to fellow travelers is not 
very high.  Gilsdorf, Morgan and Leitmeyer (2012) reviewed a few cases of people 
traveling internationally with Ebola “…the reviewed studies show a low risk of 
transmission in the early phase of symptomatic patients, even if high risk exposure 
occurred.” (p.1471). It seems that high risk exposure is “direct physical contact.” 
(p.1472). They go on to say, “ In the outbreak in 2000 in Uganda the most important 
risk factor was direct and repeated contact with a sick person’s body fluids, as occurs 
during the provision of care.” (Gilsdorf,  Morgan, & Leitmeyer, 2012, p.1472). This 
would indicate that the persons providing care over time is at greater risk and current 
events have proved this to be true. The infected persons in Spain and the United 
States are both healthcare providers. Even though the infected person traveled a great 
distance and came in contact with many people along the way, it was a nurse with 
personal protective devices (PPE) in both cases that was stricken. 
Signs and Symptoms: 
Ebola virus disease is, “characterized by a sudden onset of fever, intense 
weakness, headache, and sore throat,” reports WHO. (WHO, 2014). The CDC says the 
fever is, “greater than 101.5 Fahrenheit.”  Additional symptoms are “vomiting, 
diarrhea and unexplained hemorrhage.” (CDC, 2014). Laboratory findings “include 
low white blood cell and platelet counts and elevated liver enzymes.” (WHO, 2014).  
The CDC says screen for temps “greater than 101.5 
Fahrenheit.”  
Intense weakness 
vomiting 
Ebola virus usually infects humans through openings in the skin or mucous membranes. 
Antigen-presenting cells such as macrophages and dendrite cells (DCs) located at the site 
of infection, are primary targets of Ebola replication…the cells become functionally 
deregulated and are unable to express co-stimulatory molecules or stimulate 
lymphocytes, namely naïve T cells. Unresponsiveness of DCs to Ebola infection most 
likely contributes to the massive lymphocyte apoptosis routinely observed in clinical 
cases of infection in humans. Ebola infection of monocytes and macrophages elicits the 
release of massive amounts of pro-inflammatory cytokines and chemokines. This 
“cytokines storm” recruits additional antigen-presenting cells (APCs) to the site of 
infection, increasing the number of host to support virus replication. It also contributes 
to the pathogenesis at the late stage of disease by increasing endothelial permeability 
and vascular leakage which, in turn, foster rapid dissemination of infected APCs 
throughout the systemic circulation to release Ebola in the secondary lymphoid organs, 
lungs, liver and other ancillary sites of virus replication. (Choi & Croyle, 2013, p.566). 
More information on lymphocytes: 
Limited data from patients and more extensive data from laboratory animals indicate 
that massive lymphocyte apoptosis occurs during Ebola hemorrhagic fever and may 
contribute to the high death rate. Thus, the few patients who survive infection develop 
antibodies to the virus during the second week of illness, while fatally infected persons 
apparently undergo terminal immunosuppression similar to that with septic 
shock.(Parrino, Hotchkiss,& Bray, 2007,p.194). 
The pathophysiology of Ebola may be the answer for a vaccine or 
serum to stop the virus. Choi and Croyle (2013) report that many vaccine 
paths have been followed, trying to find a perfect result. They first used 
“Ebola proteins” but these were found to “override pre-existing 
immunity…[this]is not desirable, since high doses of adenovirus particles 
can participate severe, toxic inflammatory responses in humans.” ( p.568). 
Another vaccine approach is to give a live recombinant virus. This 
protected small rodents, but when the virus was gamma-irradiated it lost its 
ability to protect those same animals. (Choi & Croyle, 2013, p. 568). So 
other methods are also being looked at.  
Virus entry is an essential step in the virus life 
cycle and is often an attractive target for therapy, 
since inhibition of this process blocks replication 
at an early stage, significantly reducing the 
chance for the virus to evolve and develop drug 
resistance. (Choi& Croyle, 2007, p.571).  
Lastly, overproduction of pro-coagulant tissue factors is 
being explored. This is done by stimulating coagulation by 
giving factor VIIa or activating the natural anticoagulant 
protein C pathway, thus decreasing production of pro- 
inflammatory cytokines.  These along with other ways are 
being tested to save Ebola infected people. (Choi & 
Croyle,2013, p. 571). 
Significance of Pathophysiology: 
Implication for Nursing Care: 
Ebola will change nursing care now and in the future. A patient with 
a temperature will have to be questioned about recent travel and contacts. 
Park says, “First asking the patient about where they have been in the past 
month to triage those who are at highest risk of having Ebola, and also 
having a room ready for those who they suspect might be infected.” (Park, 
2014, p.2). Although, it is reported that these patients can be taken care of in 
any hospital, this may be a return of isolation rooms or wards.  
The CDC put out recommendations for hospitals caring for Ebola 
patients and those recommendations include, single patient rooms with an 
entry log, all personnel entering must wear gloves, fluid resistant gowns, 
eye protection and a face mask (PPE). If the patient is vomiting or bleeding 
double gloving, shoe covers and leg covering is recommended. Sharps must 
be handled with extreme care. If a healthcare worker is exposed to a patient 
without PPE they need to be monitored twice daily after the exposure. 
(CDC, 2014). 
In the case of death, “Handling of the remains should be kept at a 
minimum.” (CDC, 2014).The PPE listed above is used after death as well. 
The CDC reports that at the “site of death, the body should be wrapped in a 
plastic shroud. Intravenous lines and endotracheal tubes are left in place. 
The body is double bagged in a leak proof plastic bag. This is an unfortunate 
part of hospital personal now that Ebola is here.  
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Conclusion: 
A few months ago, Ebola was an African virus that Americans 
did not need to worry about, how quickly things change. America has 
had an Ebola patient die after traveling to a Texas hospital.  A nurse 
infected, is fighting for her life after contact with this man. Many 
people are being isolated that were on the plane, in the airport or 
homes were he went. These all seem like innocent everyday 
activities. 
Nurses are at a high risk to come in contact with Ebola 
patients’ body fluids without effective PPEs in place. This virus is 
going to affect many nurses. It may be positive or negative, time will 
tell. Cnn.com 
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